Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors

Purpose Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research and treatment 2018-02, Vol.167 (3), p.635-648
Hauptverfasser: Nguyen, Frédérique, Peña, Laura, Ibisch, Catherine, Loussouarn, Delphine, Gama, Adelina, Rieder, Natascha, Belousov, Anton, Campone, Mario, Abadie, Jérôme
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 648
container_issue 3
container_start_page 635
container_title Breast cancer research and treatment
container_volume 167
creator Nguyen, Frédérique
Peña, Laura
Ibisch, Catherine
Loussouarn, Delphine
Gama, Adelina
Rieder, Natascha
Belousov, Anton
Campone, Mario
Abadie, Jérôme
description Purpose Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer. Methods The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model. Results The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)]. Conclusion The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.
doi_str_mv 10.1007/s10549-017-4548-2
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A527129706</galeid><sourcerecordid>A527129706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</originalsourceid><addsrcrecordid>eNp1klGL1DAUhYso7rr6A3yRgCA-2PEmbZLJPgjDoK4woA_6HDJpOs3SJmPSDvjvvWXWdWbRthBIvnNy7-ktipcUFhRAvs8UeK1KoLKseb0s2aPiknJZlZJR-bi4BCpkKZYgLopnOd8CgJKgnhYXTMFSsIpeFnltgg-O-HAw2R8cGcwwmPSLWJOsD3EwmeA3xMb1mcSWdNNgAtkmZ_KIULAuLcg3k0ZCr0kw45RMTzqfx4gmJjRkn-IuxDx6S1pjcTs_L560ps_uxd16Vfz49PH7-qbcfP38Zb3alFZIOpZMibZlqqKc12IL9RKggmoLQmypakA41lRUthaEsrzhTCAGynAlmspin9VV8eHou5-2g2usCyMWp_fJzx3qaLw-Pwm-07t40HwJslY1Grw7GnQPZDerjfYhuzRozJgprO1AEX97d1-KPyeXRz34bF3fm-DilDVVfMkrVYkZff0AvY1TCpgGUvjQuf6_1M70Di9sI5ZpZ1O94kxShr9TILX4B4Vv4wZvY3Ctx_0zwZsTQedMP3Y59tPoY8jnID2CNsWck2vvQ6Cg5wnUxwnEEKSeJ1Az1Lw6Df1e8WfkEGBHIONR2Ll00vp_XX8DZv7jMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1999917093</pqid></control><display><type>article</type><title>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Nguyen, Frédérique ; Peña, Laura ; Ibisch, Catherine ; Loussouarn, Delphine ; Gama, Adelina ; Rieder, Natascha ; Belousov, Anton ; Campone, Mario ; Abadie, Jérôme</creator><creatorcontrib>Nguyen, Frédérique ; Peña, Laura ; Ibisch, Catherine ; Loussouarn, Delphine ; Gama, Adelina ; Rieder, Natascha ; Belousov, Anton ; Campone, Mario ; Abadie, Jérôme</creatorcontrib><description>Purpose Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer. Methods The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model. Results The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)]. Conclusion The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-017-4548-2</identifier><identifier>PMID: 29086231</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animal models ; Animals ; Breast cancer ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Cancer ; Cancer research ; Clinical trials ; Disease Models, Animal ; Dogs ; Epidermal growth factor ; Epidermal growth factor receptors ; Epidermal growth factors ; Estrogens ; Female ; Humans ; Invasiveness ; Life Sciences ; Mammary gland ; Mammary Neoplasms, Animal - genetics ; Mammary Neoplasms, Animal - pathology ; Mammary Neoplasms, Animal - surgery ; Mastectomy ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Multivariate Analysis ; Neoplasm Invasiveness - genetics ; Neoplasm Invasiveness - pathology ; Oncology ; Preclinical Study ; Progesterone ; Prognosis ; Receptor, ErbB-2 - genetics ; Receptors, Estrogen - genetics ; Receptors, Progesterone - genetics ; Survival</subject><ispartof>Breast cancer research and treatment, 2018-02, Vol.167 (3), p.635-648</ispartof><rights>The Author(s) 2017</rights><rights>COPYRIGHT 2018 Springer</rights><rights>Breast Cancer Research and Treatment is a copyright of Springer, (2017). All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</citedby><cites>FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</cites><orcidid>0000-0001-7203-2982 ; 0000-0002-3538-0782 ; 0000-0002-5196-5908 ; 0000-0002-7750-0519</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10549-017-4548-2$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10549-017-4548-2$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29086231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-01629480$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Frédérique</creatorcontrib><creatorcontrib>Peña, Laura</creatorcontrib><creatorcontrib>Ibisch, Catherine</creatorcontrib><creatorcontrib>Loussouarn, Delphine</creatorcontrib><creatorcontrib>Gama, Adelina</creatorcontrib><creatorcontrib>Rieder, Natascha</creatorcontrib><creatorcontrib>Belousov, Anton</creatorcontrib><creatorcontrib>Campone, Mario</creatorcontrib><creatorcontrib>Abadie, Jérôme</creatorcontrib><title>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>Purpose Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer. Methods The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model. Results The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)]. Conclusion The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.</description><subject>Animal models</subject><subject>Animals</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Cancer</subject><subject>Cancer research</subject><subject>Clinical trials</subject><subject>Disease Models, Animal</subject><subject>Dogs</subject><subject>Epidermal growth factor</subject><subject>Epidermal growth factor receptors</subject><subject>Epidermal growth factors</subject><subject>Estrogens</subject><subject>Female</subject><subject>Humans</subject><subject>Invasiveness</subject><subject>Life Sciences</subject><subject>Mammary gland</subject><subject>Mammary Neoplasms, Animal - genetics</subject><subject>Mammary Neoplasms, Animal - pathology</subject><subject>Mammary Neoplasms, Animal - surgery</subject><subject>Mastectomy</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Oncology</subject><subject>Preclinical Study</subject><subject>Progesterone</subject><subject>Prognosis</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Receptors, Estrogen - genetics</subject><subject>Receptors, Progesterone - genetics</subject><subject>Survival</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1klGL1DAUhYso7rr6A3yRgCA-2PEmbZLJPgjDoK4woA_6HDJpOs3SJmPSDvjvvWXWdWbRthBIvnNy7-ktipcUFhRAvs8UeK1KoLKseb0s2aPiknJZlZJR-bi4BCpkKZYgLopnOd8CgJKgnhYXTMFSsIpeFnltgg-O-HAw2R8cGcwwmPSLWJOsD3EwmeA3xMb1mcSWdNNgAtkmZ_KIULAuLcg3k0ZCr0kw45RMTzqfx4gmJjRkn-IuxDx6S1pjcTs_L560ps_uxd16Vfz49PH7-qbcfP38Zb3alFZIOpZMibZlqqKc12IL9RKggmoLQmypakA41lRUthaEsrzhTCAGynAlmspin9VV8eHou5-2g2usCyMWp_fJzx3qaLw-Pwm-07t40HwJslY1Grw7GnQPZDerjfYhuzRozJgprO1AEX97d1-KPyeXRz34bF3fm-DilDVVfMkrVYkZff0AvY1TCpgGUvjQuf6_1M70Di9sI5ZpZ1O94kxShr9TILX4B4Vv4wZvY3Ctx_0zwZsTQedMP3Y59tPoY8jnID2CNsWck2vvQ6Cg5wnUxwnEEKSeJ1Az1Lw6Df1e8WfkEGBHIONR2Ll00vp_XX8DZv7jMg</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Nguyen, Frédérique</creator><creator>Peña, Laura</creator><creator>Ibisch, Catherine</creator><creator>Loussouarn, Delphine</creator><creator>Gama, Adelina</creator><creator>Rieder, Natascha</creator><creator>Belousov, Anton</creator><creator>Campone, Mario</creator><creator>Abadie, Jérôme</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7203-2982</orcidid><orcidid>https://orcid.org/0000-0002-3538-0782</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0002-7750-0519</orcidid></search><sort><creationdate>20180201</creationdate><title>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</title><author>Nguyen, Frédérique ; Peña, Laura ; Ibisch, Catherine ; Loussouarn, Delphine ; Gama, Adelina ; Rieder, Natascha ; Belousov, Anton ; Campone, Mario ; Abadie, Jérôme</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c671t-296ff29315546b04800303b066b19d06e2d317fc069c5d52654609a596d3c7093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Cancer</topic><topic>Cancer research</topic><topic>Clinical trials</topic><topic>Disease Models, Animal</topic><topic>Dogs</topic><topic>Epidermal growth factor</topic><topic>Epidermal growth factor receptors</topic><topic>Epidermal growth factors</topic><topic>Estrogens</topic><topic>Female</topic><topic>Humans</topic><topic>Invasiveness</topic><topic>Life Sciences</topic><topic>Mammary gland</topic><topic>Mammary Neoplasms, Animal - genetics</topic><topic>Mammary Neoplasms, Animal - pathology</topic><topic>Mammary Neoplasms, Animal - surgery</topic><topic>Mastectomy</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Oncology</topic><topic>Preclinical Study</topic><topic>Progesterone</topic><topic>Prognosis</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Receptors, Estrogen - genetics</topic><topic>Receptors, Progesterone - genetics</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Frédérique</creatorcontrib><creatorcontrib>Peña, Laura</creatorcontrib><creatorcontrib>Ibisch, Catherine</creatorcontrib><creatorcontrib>Loussouarn, Delphine</creatorcontrib><creatorcontrib>Gama, Adelina</creatorcontrib><creatorcontrib>Rieder, Natascha</creatorcontrib><creatorcontrib>Belousov, Anton</creatorcontrib><creatorcontrib>Campone, Mario</creatorcontrib><creatorcontrib>Abadie, Jérôme</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Frédérique</au><au>Peña, Laura</au><au>Ibisch, Catherine</au><au>Loussouarn, Delphine</au><au>Gama, Adelina</au><au>Rieder, Natascha</au><au>Belousov, Anton</au><au>Campone, Mario</au><au>Abadie, Jérôme</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>167</volume><issue>3</issue><spage>635</spage><epage>648</epage><pages>635-648</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><abstract>Purpose Dogs have been proposed as spontaneous animal models of human breast cancer, based on clinicopathologic similarities between canine and human mammary carcinomas. We hypothesized that a better knowledge of the natural history and prognostic factors of canine invasive mammary carcinomas would favor the design of preclinical trials using dogs as models of breast cancer. Methods The 2-year outcome of 350 female dogs with spontaneous invasive mammary carcinoma was studied. The investigated prognostic factors included age at diagnosis, pathologic tumor size, pathologic nodal stage, lymphovascular invasion, histological grade, and expression of Estrogen Receptor alpha (ERα), Progesterone Receptor, Ki-67, Human Epidermal Growth Factor Receptor 2, basal cytokeratins 5/6, and Epidermal Growth Factor Receptor. Multivariate survival analyses were performed using the Cox proportional hazards model. Results The overall survival after mastectomy was 11 months. Within 1 year post mastectomy, 41.5% of dogs (145/350) died from their mammary carcinoma. By multivariate analysis, the significant prognostic factors for overall survival included a pathologic tumor size larger than 20 mm [HR 1.47 (95% confidence interval 1.15–1.89)], a positive nodal stage [pN+, HR 1.89 (1.43–2.48)], a histological grade III [HR 1.32 (1.02–1.69)], ERα negativity [HR 1.39 (1.01–1.89)], a high Ki-67 proliferation index [HR 1.32 (1.04–1.67)], and EGFR absence [HR 1.33 (1.04–1.69)]. Conclusion The short natural history of spontaneous canine invasive mammary carcinomas and high rate of cancer-related death allow for rapid termination of preclinical investigations. The prognostic factors of invasive mammary carcinomas are remarkably similar in dogs and humans, highlighting the similarities in cancer biology between both species.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29086231</pmid><doi>10.1007/s10549-017-4548-2</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-7203-2982</orcidid><orcidid>https://orcid.org/0000-0002-3538-0782</orcidid><orcidid>https://orcid.org/0000-0002-5196-5908</orcidid><orcidid>https://orcid.org/0000-0002-7750-0519</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-6806
ispartof Breast cancer research and treatment, 2018-02, Vol.167 (3), p.635-648
issn 0167-6806
1573-7217
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5807494
source MEDLINE; SpringerNature Journals
subjects Animal models
Animals
Breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Cancer
Cancer research
Clinical trials
Disease Models, Animal
Dogs
Epidermal growth factor
Epidermal growth factor receptors
Epidermal growth factors
Estrogens
Female
Humans
Invasiveness
Life Sciences
Mammary gland
Mammary Neoplasms, Animal - genetics
Mammary Neoplasms, Animal - pathology
Mammary Neoplasms, Animal - surgery
Mastectomy
Medical prognosis
Medicine
Medicine & Public Health
Multivariate Analysis
Neoplasm Invasiveness - genetics
Neoplasm Invasiveness - pathology
Oncology
Preclinical Study
Progesterone
Prognosis
Receptor, ErbB-2 - genetics
Receptors, Estrogen - genetics
Receptors, Progesterone - genetics
Survival
title Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A17%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Canine%20invasive%20mammary%20carcinomas%20as%20models%20of%20human%20breast%20cancer.%20Part%201:%20natural%20history%20and%20prognostic%20factors&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=Nguyen,%20Fr%C3%A9d%C3%A9rique&rft.date=2018-02-01&rft.volume=167&rft.issue=3&rft.spage=635&rft.epage=648&rft.pages=635-648&rft.issn=0167-6806&rft.eissn=1573-7217&rft_id=info:doi/10.1007/s10549-017-4548-2&rft_dat=%3Cgale_pubme%3EA527129706%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1999917093&rft_id=info:pmid/29086231&rft_galeid=A527129706&rfr_iscdi=true